We value your privacy. Your user session will expire in 2 minutes. To stay logged in, please refresh the page or, if you are working
on a form, click on the submit button to save your work. Click here to refresh now (you will lose any unsaved work).

Recommendation Video Presentation on Second Line Chemo for Advanced NSCLC

Updated Jan 6, 2010, filed in All Journey Phases, Lung Cancer
One of the core issues in managing advanced NSCLC is second line chemotherapy, which was established as improving survival several years ago. This video presentation provides a brief summary of the work that led to the common use of chemotherapy in previously treated patients. Most typically, this is taxotere (docetaxel) or alimta (pemetrexed), and this presentation describes why we focus most commonly on these chemo agents.
Sidebar_loader